SEARCH

SEARCH BY CITATION

References

  • Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R & Tschopp J (2003) Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med 197: 263268.
  • Cao Z, Xiong J, Takeuchi M, Kurama T & Goeddel DV (1996) TRAF6 is a signal transducer for interleukin-1. Nature 383: 443446.
  • Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, Cody MJ, Michalek SM, Rice NR & Vogel SN (2003) Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR “homotolerance” versus “heterotolerance” on NF-κB signaling pathway components. J Immunol 170: 508519.
  • Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H & Ikeda H (2003) Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100: 171194.
  • Hatao F, Muroi M, Hiki N, Ogawa T, Mimura Y, Kaminishi M & Tanamoto K (2004) Prolonged Toll-like receptor stimulation leads to down-regulation of IRAK-4 protein. J Leukoc Biol 76: 904908.
  • Jacinto R, Hartung T, McCall C & Li L (2002) Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol 168: 61366141.
  • Janssens S & Beyaert R (2003) Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell 11: 293302.
  • Kanakaraj P, Schafer PH, Cavender DE et al. (1998) Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J Exp Med 187: 20732079.
  • Kawagoe T, Sato S, Jung A, Yamamoto M, Matsui K, Kato H, Uematsu S, Takeuchi O & Akira S (2007) Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J Exp Med 204: 10131024.
  • Kim TW, Staschke K, Bulek K et al. (2007) A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med 204: 10251036.
  • Koziczak-Holbro M, Joyce C, Gluck A, Kinzel B, Muller M, Tschopp C, Mathison JC, Davis CN & Gram H (2007) IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression. J Biol Chem 282: 1355213560.
  • Li S, Strelow A, Fontana EJ & Wesche H (2002) IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci USA 99: 55675572.
  • Lye E, Mirtsos C, Suzuki N, Suzuki S & Yeh WC (2004) The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling. J Biol Chem 279: 4065340658.
  • Medvedev AE, Thomas K, Awomoyi A, Kuhns DB, Gallin JI, Li X & Vogel SN (2005) Expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters normal IRAK-4 interaction with components of the IL-1 receptor complex. J Immunol 174: 65876591.
  • Muroi M & Tanamoto K (2002) The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-κB through human Toll-like receptor 4. Infect Immun 70: 60436047.
  • Muroi M, Ohnishi T & Tanamoto K (2002) MD-2, a novel accessory molecule, is involved in species-specific actions of Salmonella lipid A. Infect Immun 70: 35463550.
  • Picard C, Puel A, Bonnet M et al. (2003) Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299: 20762079.
  • Qin J, Jiang Z, Qian Y, Casanova JL & Li X (2004) IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness. J Biol Chem 279: 2674826753.
  • Sato S, Takeuchi O, Fujita T, Tomizawa H, Takeda K & Akira S (2002) A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int Immunol 14: 783791.
  • Suzuki N, Suzuki S, Duncan GS et al. (2002) Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750756.
  • Thomas JA, Allen JL, Tsen M, Dubnicoff T, Danao J, Liao XC, Cao Z & Wasserman SA (1999) Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J Immunol 163: 978984.
  • Yeo SJ, Yoon JG, Hong SC & Yi AK (2003) CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: alterations in IL-1 receptor-associated kinase expression. J Immunol 170: 10521061.